Novartis AG vs iShares TIPS Bond ETF — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while iShares TIPS Bond ETF trades at $107.93. The key difference: Novartis AG pays a 3.17% dividend while iShares TIPS Bond ETF pays none, and Novartis AG is trading nearer its 52-week high, iShares TIPS Bond ETF nearer its low. Which is the better fit depends on your goals.
| NVS | TIP | |
|---|---|---|
Market Cap | $290.25B | — |
Sector | Health | Fixed Income |
52-Week High | $168.62 | $112.20 |
52-Week Low | $113.50 | $107.91 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →TIP is the flagship ETF for U.S. Treasury Inflation-Protected Securities (TIPS). It tracks an index of government bonds whose principal value adjusts based on the Consumer Price Index (CPI), providing a direct hedge against rising inflation.
Read more on TIP →